https://www.reedland.com/wp-content/uploads/2017/04/Ariad-Pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2007-02-15 11:40:052017-04-26 11:43:34Ariad Pharmaceuticals Reports 4th-Quarter Results and Enters Financing Deal
https://www.reedland.com/wp-content/uploads/2017/04/Depomed.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-12-12 11:43:522017-04-26 11:48:19Depomed Announces Equity Financing Commitment of Up to $30 Million
https://www.reedland.com/wp-content/uploads/2017/04/Encysive-Pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-10-19 11:48:422017-04-26 11:54:11Encysive Pharmaceuticals Secures Equity Financing Commitment
https://www.reedland.com/wp-content/uploads/2017/04/Onyx.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-09-29 11:54:472017-04-26 11:58:16Onyx Secures Equity Financing Commitment
https://www.reedland.com/wp-content/uploads/2017/04/Solexa.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-09-20 11:58:252017-04-26 12:01:41Solexa Secures Two-Year Equity Financing Commitment
https://www.reedland.com/wp-content/uploads/2017/04/Tutogen.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-06-30 12:01:552017-04-26 12:09:28Tutogen Medical Closes $3.0 Million Private Placement
https://www.reedland.com/wp-content/uploads/2017/04/Lexicon.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-06-13 12:09:432017-04-26 12:12:58Lexicon, Azimuth Structure Stock Equity Financing Deal
https://www.reedland.com/wp-content/uploads/2017/04/Isis-Pharma.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-05-30 12:13:122017-04-26 12:17:12Isis Pharmaceuticals Receives $75 Million Equity Financing Commitment
https://www.reedland.com/wp-content/uploads/2017/04/CV-Therapeutics.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-04-18 12:17:252017-04-26 12:20:25CV Therapeutics Secures Three Year Equity Financing Commitment
https://www.reedland.com/wp-content/uploads/2017/04/BIO-Convention.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2006-04-10 12:20:402017-04-26 12:25:02Rob Schacter to Participate in Panel Session at BIO 2006 Annual Convention
https://www.reedland.com/wp-content/uploads/2017/04/Nektar-Therapeutics.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2005-09-08 12:25:232017-04-26 12:29:01Nektar Announces Investor’s Election to Acquire $8M of Nektar’s Common Stock
https://www.reedland.com/wp-content/uploads/2017/04/Nektar-Therapeutics.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2005-08-16 12:29:072017-04-26 12:30:44Nektar Therapeutics Announces $24 Million Common Stock Financing
Scroll to top